MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes

Biochemical and Biophysical Research Communications

Volumn 389, Issue 2, 2009, Pages 315-320

  Horie, Takahiro ^a   Ono, Koh ^a   Nishi, Hitoo ^a   Iwanaga, Yoshitaka ^b   Nagao, Kazuya ^a   Kinoshita, Minako ^a   Kuwabara, Yasuhide ^a   Takanabe, Rieko ^c   Hasegawa, Koji ^c   Kita, Toru ^a   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

Author keywords

Cardiomyocyte; GLUT4; MicroRNA

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; KRUPPEL LIKE FACTOR 15; MICRORNA; MICRORNA 133; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALGORITHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; METABOLIC REGULATION; NEWBORN; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BASE SEQUENCE; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 4; HEART FAILURE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICRORNAS; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; RATS; RATS, INBRED DAHL;

RATTUS;

EID: 70349309314     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.08.136     Document Type: Article

References (32)

1. Marin-Garcia J., Goldenthal M.J., and Moe G.W. Mitochondrial pathology in cardiac failure. Cardiovasc. Res. 49 (2001) 17-26
2. Neubauer S., Krahe T., Schindler R., Horn M., Hillenbrand H., Entzeroth C., Mader H., Kromer E.P., Riegger G.A., Lackner K., et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86 (1992) 1810-1818
3. Horn M., Remkes H., Stromer H., Dienesch C., and Neubauer S. Chronic phosphocreatine depletion by the creatine analogue beta-guanidinopropionate is associated with increased mortality and loss of ATP in rats after myocardial infarction. Circulation 104 (2001) 1844-1849
4. Cross H.R., Opie L.H., Radda G.K., and Clarke K. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ. Res. 78 (1996) 482-491
5. Tian R., and Abel E.D. Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis. Circulation 103 (2001) 2961-2966
6. Takanabe R., Ono K., Abe Y., Takaya T., Horie T., Wada H., Kita T., Satoh N., Shimatsu A., and Hasegawa K. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem. Biophys. Res. Commun. 376 (2008) 728-732
7. Krutzfeldt J., and Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 4 (2006) 9-12
8. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., and Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38 (2006) 228-233
9. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., and Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 103 (2006) 18255-18260
10. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M.L., Segnalini P., Gu Y., Dalton N.D., Elia L., Latronico M.V., Hoydal M., Autore C., Russo M.A., Dorn II G.W., Ellingsen O., Ruiz-Lozano P., Peterson K.L., Croce C.M., Peschle C., and Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13 (2007) 613-618
11. Sayed D., Hong C., Chen I.Y., Lypowy J., and Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ. Res. 100 (2007) 416-424
12. Paolisso G., De Riu S., Marrazzo G., Verza M., Varricchio M., and D'Onofrio F. Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 40 (1991) 972-977
13. Swan J.W., Anker S.D., Walton C., Godsland I.F., Clark A.L., Leyva F., Stevenson J.C., and Coats A.J. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J. Am. Coll. Cardiol. 30 (1997) 527-532
14. Kemppainen J., Tsuchida H., Stolen K., Karlsson H., Bjornholm M., Heinonen O.J., Nuutila P., Krook A., Knuuti J., and Zierath J.R. Insulin signalling and resistance in patients with chronic heart failure. J. Physiol. 550 (2003) 305-315
15. Paternostro G., Camici P.G., Lammerstma A.A., Marinho N., Baliga R.R., Kooner J.S., Radda G.K., and Ferrannini E. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J. Clin. Invest. 98 (1996) 2094-2099
16. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., and Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc. Res. 42 (1999) 246-253
17. Inoko M., Kihara Y., Morii I., Fujiwara H., and Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am. J. Physiol. 267 (1994) H2471-H2482
18. Inada T., Fujiwara H., Hasegawa K., Araki M., Yamauchi-Kohno R., Yabana H., Fujiwara T., Tanaka M., and Sasayama S. Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters. J. Am. Coll. Cardiol. 33 (1999) 565-571
19. Horie T., Ono K., Nagao K., Nishi H., Kinoshita M., Kawamura T., Wada H., Shimatsu A., Kita T., and Hasegawa K. Oxidative stress induces GLUT4 translocation by activation of PI3-K/Akt and dual AMPK kinase in cardiac myocytes. J. Cell. Physiol. 215 (2008) 733-742
20. Horie T., Ono K., Kinoshita M., Nishi H., Nagao K., Kawamura T., Abe Y., Wada H., Shimatsu A., Kita T., and Hasegawa K. TG-interacting factor is required for the differentiation of preadipocytes. J. Lipid Res. 49 (2008) 1224-1234
21. Ventura-Clapier R., Garnier A., and Veksler V. Energy metabolism in heart failure. J. Physiol. 555 (2004) 1-13
22. Stanley W.C., Recchia F.A., and Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85 (2005) 1093-1129
23. Becker C., Sevilla L., Tomas E., Palacin M., Zorzano A., and Fischer Y. The endosomal compartment is an insulin-sensitive recruitment site for GLUT4 and GLUT1 glucose transporters in cardiac myocytes. Endocrinology 142 (2001) 5267-5276
24. Fischer Y., Thomas J., Sevilla L., Munoz P., Becker C., Holman G., Kozka I.J., Palacin M., Testar X., Kammermeier H., and Zorzano A. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J. Biol. Chem. 272 (1997) 7085-7092
25. Liu N., Bezprozvannaya S., Williams A.H., Qi X., Richardson J.A., Bassel-Duby R., and Olson E.N. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22 (2008) 3242-3254
26. Shepherd P.R., and Kahn B.B. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 341 (1999) 248-257
27. Katz E.B., Burcelin R., Tsao T.S., Stenbit A.E., and Charron M.J. The metabolic consequences of altered glucose transporter expression in transgenic mice. J. Mol. Med. 74 (1996) 639-652
28. Gerrits P.M., Olson A.L., and Pessin J.E. Regulation of the GLUT4/muscle-fat glucose transporter mRNA in adipose tissue of insulin-deficient diabetic rats. J. Biol. Chem. 268 (1993) 640-644
29. Thai M.V., Guruswamy S., Cao K.T., Pessin J.E., and Olson A.L. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J. Biol. Chem. 273 (1998) 14285-14292
30. Charron M.J., Katz E.B., and Olson A.L. GLUT4 gene regulation and manipulation. J. Biol. Chem. 274 (1999) 3253-3256
31. Gray S., Feinberg M.W., Hull S., Kuo C.T., Watanabe M., Sen-Banerjee S., DePina A., Haspel R., and Jain M.K. The Kruppel-like factor KLF15 regulates the insulin-sensitive glucose transporter GLUT4. J. Biol. Chem. 277 (2002) 34322-34328
32. Fisch S., Gray S., Heymans S., Haldar S.M., Wang B., Pfister O., Cui L., Kumar A., Lin Z., Sen-Banerjee S., Das H., Petersen C.A., Mende U., Burleigh B.A., Zhu Y., Pinto Y.M., Liao R., and Jain M.K. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA 104 (2007) 7074-7079